Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML Topical Cream — RxCUI 1435154
RxNorm drug concept · Semantic clinical drug
RxCUI 1435154
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1435154
Official nameUndecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asundecylenic acid 5 % / zinc undecylenate 18 % Topical Cream
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Undecylenic: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats three common fungal skin infections: athlete's foot (the itchy, scaly condition that affects the feet and toes), jock itch (a fungal rash in the groin area), and ringworm...
- What exactly does undecylenic acid treat?
- For athlete's foot and ringworm, most products are used daily for 4 full weeks. For jock itch, 2 weeks of daily use is typically recommended. Some nail products note that visible i...
- That depends on the product. Most undecylenic acid creams, sprays, and general topical solutions are not effective on nails and should not be used there. However, some products — l...
🕸️ Concept Web — How Undecylenic acid 50 MG/ML / zinc undecylenate 18... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML Topical Cream
RxCUI 1435154 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Undecylenate
314881IN -
Undecylenic acid / zinc undecylenate
694012MIN -
Undecylenic acid
10989PIN -
Zinc undecylenate
89748PIN
-
Undecylenate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Derman
2380341BN
-
Derman
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Undecylenate Topical Cream
377835SCDF -
Undecylenic acid / zinc undecylenate Topical Cream
2645356SCDFP -
Undecylenate Topical Product
1159957SCDG -
Undecylenic acid / zinc undecylenate Topical Product
2661602SCDGP -
Undecylenate Topical Cream [Derman]
2380347SBDF -
Undecylenic acid / zinc undecylenate Topical Cream [Derman]
2654680SBDFP -
Derman Topical Product
2380344SBDG -
Topical Cream
316982DF - +1 more in this family
-
Undecylenate Topical Cream
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Undecylenic acid 50 MG/ML
384555SCDC -
Zinc undecylenate 180 MG/ML
1435153SCDC -
Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML Topical Cream [Derman]
1435159SBD -
Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML [Derman]
2380346SBDC
-
Undecylenic acid 50 MG/ML
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Undecylenic acid 50 MG/ML
SCDC · 384555 -
Zinc undecylenate 180 MG/ML
SCDC · 1435153 -
Undecylenate Topical Cream
SCDF · 377835 -
Undecylenic acid / zinc undecylenate Topical Cream
SCDFP · 2645356 -
Undecylenate Topical Product
SCDG · 1159957 -
Undecylenic acid / zinc undecylenate Topical Product
SCDGP · 2661602
Brand-Name Concepts
-
Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML Topical Cream [Derman]
SBD · 1435159 -
Undecylenic acid 50 MG/ML / zinc undecylenate 180 MG/ML [Derman]
SBDC · 2380346 -
Undecylenate Topical Cream [Derman]
SBDF · 2380347 -
Undecylenic acid / zinc undecylenate Topical Cream [Derman]
SBDFP · 2654680 -
Derman Topical Product
SBDG · 2380344 -
Derman
BN · 2380341
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1435154 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 54312-0125-01 | 1 TUBE in 1 CARTON (54312-125-01) / 25 g in 1 TUBE | Derman Antifungal | Compania Internacional de Comercio, S.A.P.I de C.V. | 2013-08-12 |
| 54312-0125-02 | 1 TUBE in 1 CARTON (54312-125-02) / 50 g in 1 TUBE | Derman Antifungal | Compania Internacional de Comercio, S.A.P.I de C.V. | 2013-08-12 |
Observed labelers:
Compania Internacional de Comercio, S.A.P.I de C.V. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.